Feedback | Thursday, November 07, 2024

October 15, 2024 7:25 PM

Britain to study use of weight loss drug to get people back to work

Britain will study whether the use of Eli Lilly's weight loss drug can get people back into work and help tackle the high rate of long-term sickness that has become a major drag on the economy. Health minister Wes Streeting predicted the use of the drug - a competitor to Novo Nordisk's Ozempic - could help transform the health of the nation, after Lilly announced a 279 million pound ($365 million) investment in Britain as part of a flagship summit hosted by Prime Minister Keir Starmer. The dea...

August 1, 2024 5:23 PM

Lilly says weight loss drug cut heart failure risk by 38% in trial

Trial results show Eli Lilly's weight loss drug Zepbound reduces the risk of hospitalization, death and other outcomes for obese adults with a common type of heart failure, the company said on Thursday as it continues to build a case for the medication's wider health benefits. The drug, also known as tirzepatide, reduced the risk of a composite of heart failure urgent visit or hospitalization, oral diuretic intensification or cardiovascular death by 38% compared to a placebo. The trial enrolle...

Copyright © 2024 DD News. All rights reserved
Visitors: 10815984
Last Updated: 7th Nov 2024